Nigeria's Pharmaceutical Sector Hobbled by Poor Infrastructure and Weak Financing.
The Nigeria Academy of Pharmacy has identified poor infrastructure, weak financing, and policy gaps as major barriers slowing pharmaceutical innovation and industry growth in Nigeria.
The Nigeria Academy of Pharmacy (NAPHARM) has identified poor infrastructure, weak financing, and policy gaps as major factors hindering pharmaceutical innovation and industry growth in the country. These barriers are slowing down the development of new medicines and treatments in Nigeria, affecting the overall health and wellbeing of its population. The academy's report highlights the need for improved funding, better regulatory frameworks, and upgraded infrastructure to support the growth of the pharmaceutical sector. By addressing these gaps, NAPHARM hopes to stimulate innovation and improve healthcare outcomes in Nigeria.
